Literature DB >> 10229235

Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming.

M Plebanski1, E A Lee, C M Hannan, K L Flanagan, S C Gilbert, M B Gravenor, A V Hill.   

Abstract

Variation in epitopes of infectious pathogens inhibits various effector functions of T lymphocytes through antagonism of the T-cell receptor. However, a more powerful strategy for immune evasion would be to prevent the induction of T-cell responses. We report here mutual 'interference' with the priming of human T-cell responses by a pair of naturally occurring variants of a malaria cytotoxic T-cell epitope. Interference with priming also occurs in vivo for a murine malaria T-cell epitope. Reshaping of the T-cell repertoire by such immune interference during naive T-cell induction may provide a general mechanism for observed patterns of immunodominance and persistence by many polymorphic pathogens.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229235     DOI: 10.1038/8444

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  26 in total

1.  The cytotoxic T-lymphocyte epitope of the Plasmodium falciparum circumsporozoite protein also modulates the efficiency of receptor-ligand interaction with hepatocytes.

Authors:  D Rathore; T F McCutchan
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor.

Authors:  Vasso Apostolopoulos; Elizabeth Yuriev; Paul A Ramsland; Jodie Halton; Carla Osinski; Wenjun Li; Magdalena Plebanski; Hans Paulsen; Ian F C McKenzie
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

Review 3.  Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations.

Authors:  Magdalena Plebanski; Owen Proudfoot; Dodie Pouniotis; Ross L Coppel; Vasso Apostolopoulos; Graham Flannery
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

4.  A cluster of four surface antigen genes specifically expressed in bradyzoites, SAG2CDXY, plays an important role in Toxoplasma gondii persistence.

Authors:  Jeroen P J Saeij; Gustavo Arrizabalaga; John C Boothroyd
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

5.  Bacterial peptides are intensively present throughout the human proteome.

Authors:  Brett Trost; Anthony Kusalik; Guglielmo Lucchese; Darja Kanduc
Journal:  Self Nonself       Date:  2010-01

6.  An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.

Authors:  Christopher S Eickhoff; Daniel Van Aartsen; Frances E Terry; Sheba K Meymandi; Mahmoud M Traina; Salvador Hernandez; William D Martin; Leonard Moise; Annie S De Groot; Daniel F Hoft
Journal:  Hum Vaccin Immunother       Date:  2015-06-24       Impact factor: 3.452

Review 7.  T cell recognition of weak ligands: roles of signaling, receptor number, and affinity.

Authors:  Lindsay J Edwards; Brian D Evavold
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

8.  Plasmodium falciparum genotypes, low complexity of infection, and resistance to subsequent malaria in participants in the Asembo Bay Cohort Project.

Authors:  O H Branch; S Takala; S Kariuki; B L Nahlen; M Kolczak; W Hawley; A A Lal
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

9.  Short-term antigen presentation and single clonal burst limit the magnitude of the CD8(+) T cell responses to malaria liver stages.

Authors:  Julius C R Hafalla; Gen-ichiro Sano; Luzia H Carvalho; Alexandre Morrot; Fidel Zavala
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-15       Impact factor: 11.205

10.  Natural selection maintains a stable polymorphism at the circumsporozoite protein locus of Plasmodium falciparum in a low endemic area.

Authors:  Chaturong Putaporntip; Somchai Jongwutiwes; Austin L Hughes
Journal:  Infect Genet Evol       Date:  2009-02-27       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.